Table of Contents
ISRN Oncology
Volume 2012, Article ID 832109, 4 pages
http://dx.doi.org/10.5402/2012/832109
Clinical Study

The Distribution of PSA Age-Specific Profiles in Healthy Irish Men between 20 and 70

1The Adelaide and Meath Hospital-Dublin, Incorporating The National Children's Hospital, Tallaght, Dublin 24, Ireland
2Department of Biostatistics, Royal College of Surgeons in Ireland, 123 Street Stephen’s Green, Dublin 2, Ireland
3Marjorie White Flynn, Department of Urology, The Adelaide and Meath Hospital-Dublin, Incorporating The National Children's Hospital, Tallaght, Dublin 24, Ireland

Received 16 April 2012; Accepted 10 June 2012

Academic Editors: N. A. Franken, N. Fujimoto, A. M. Garcia-Lora, L. Mutti, C.-X. Pan, and C. Perez

Copyright © 2012 R. G. Casey et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Ferlay, P. Autier, M. Boniol, M. Heanue, M. Colombet, and P. Boyle, “Estimates of the cancer incidence and mortality in Europe in 2006,” Annals of Oncology, vol. 18, no. 3, pp. 581–592, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Comber, Trends in Irish cancer incidence 1994–2002 with projections to 2020.
  3. R. J. Ablin, W. A. Soanes, P. Bronson, and E. Witebsky, “Precipitating antigens of the normal human prostate,” Journal of Reproduction and Fertility, vol. 22, no. 3, pp. 573–574, 1970. View at Google Scholar · View at Scopus
  4. T. A. Stamey, N. Yang, and A. R. Hay, “Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate,” The New England Journal of Medicine, vol. 317, no. 15, pp. 909–916, 1987. View at Google Scholar · View at Scopus
  5. P. C. Walsh, “Using prostate-specific antigen to diagnose prostate cancer: sailing in uncharted waters,” Annals of Internal Medicine, vol. 119, no. 9, pp. 948–949, 1993. View at Google Scholar · View at Scopus
  6. S. Loeb, R. B. Nadler, K. A. Roehl, J. A. V. Antenor, and W. J. Catalona, “Risk of prostate cancer for young men with a prostate specific antigen less than their age specific median,” Journal of Urology, vol. 177, no. 5, pp. 1745–1748, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Senior, “Age-specific PSA screening better,” The Lancet Oncology, vol. 8, no. 5, article 378, 2007. View at Google Scholar · View at Scopus
  8. J. Oesterling, “Age-specific reference ranges for serum PSA,” The New England Journal of Medicine, vol. 335, no. 5, pp. 345–346, 1996. View at Publisher · View at Google Scholar · View at Scopus
  9. I. M. Thompson, D. K. Pauler, P. J. Goodman et al., “Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter,” The New England Journal of Medicine, vol. 350, no. 22, pp. 2239–2246, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. J. E. Oesterling, Y. Kumamoto, T. Tsukamoto et al., “Serum prostate-specific antigen in a community-based population of healthy Japanese men: lower values than for similarly aged white men,” British Journal of Urology, vol. 75, no. 3, pp. 347–353, 1995. View at Google Scholar · View at Scopus
  11. M. C. Weinrich, S. J. Jacobsen, S. P. Weinrich et al., “Reference ranges for serum prostate-specific antigen in black and white men without cancer,” Urology, vol. 52, no. 6, pp. 967–973, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. S. E. Lee, C. Kwak, M. S. Park, C. H. Lee, W. Kang, and S. J. Oh, “Ethnic differences in the age-related distribution of serum prostate-specific antigen values: a study in a healthy Korean male population,” Urology, vol. 56, no. 6, pp. 1007–1010, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. D. He, M. Wang, X. Chen et al., “Ethnic differences in distribution of serum prostate-specific antigen: a study in a healthy Chinese male population,” Urology, vol. 63, no. 4, pp. 722–726, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. Z. Y. Liu, Y. H. Sun, C. L. Xu, X. Gao, L. M. Zhang, and S. C. Ren, “Age-specific PSA reference ranges in Chinese men without prostate cancer,” Asian Journal of Andrology, vol. 11, no. 1, pp. 100–103, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. M. N. G. Battikhi, “Age-specific reference ranges for prostate-specific antigen (PSA) in Jordanian patients,” Prostate Cancer and Prostatic Diseases, vol. 6, no. 3, pp. 256–260, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. T. O. Morgan, S. J. Jacobsen, W. F. Mccarthy, D. J. Jacobson, D. G. Mcleod, and J. W. Moul, “Age-specific reference ranges for serum prostate-specific antigen in black men,” The New England Journal of Medicine, vol. 335, no. 5, pp. 304–310, 1996. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Sawyer, J. J. Berman, A. Borkowski, and G. W. Moore, “Elevated prostate-specific antigen levels in Black men and White men,” Modern Pathology, vol. 9, no. 11, pp. 1029–1032, 1996. View at Google Scholar · View at Scopus
  18. M. J. Barry, “Prostate-specific-antigen testing for early diagnosis of prostate cancer,” The New England Journal of Medicine, vol. 344, no. 18, pp. 1373–1377, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. J. E. Oesterling, S. J. Jacobsen, C. G. Chute et al., “Serum prostate-specific antigen in a community-based population of healthy men: establishment of age-specific reference ranges,” JAMA, vol. 270, no. 7, pp. 860–864, 1993. View at Publisher · View at Google Scholar · View at Scopus
  20. E. P. Deantoni, E. D. Crawford, J. E. Oesterling et al., “Age- and race-specific reference ranges for prostate-specific antigen from a large community-based study,” Urology, vol. 48, no. 2, pp. 234–239, 1996. View at Publisher · View at Google Scholar · View at Scopus
  21. K. J. Lin, S. T. Pang, Y. H. Chang et al., “Age-related reference levels of serum prostate-specific antigen among taiwanese men without clinical evidence of prostate cancer,” Chang Gung Medical Journal, vol. 33, no. 2, pp. 182–187, 2010. View at Google Scholar · View at Scopus